|
2020
|
Invention
|
Peripheral alkyl and alkenyl chains extended benzene derivatives and pharmaceutical composition i... |
|
2019
|
Invention
|
Nadph oxidase inhibitors, pharmaceutical composition comprising the same, and application thereof... |
|
|
Invention
|
Prodrugs of naltrexone, nalmefene and derivatives thereof. A novel structure of an opioid antagon... |
|
|
Invention
|
Pharmaceutical formulation for a solid dosage form of opioid receptor antagonists.
The present d... |
|
|
Invention
|
Pharmaceutical formulation for a solid dosage form of opioid receptor antagonists. The present di... |
|
2018
|
Invention
|
Benzene fused heterocyclic compound and use thereof.
The present disclosure provides a benzene f... |
|
|
Invention
|
Benzene fused heterocyclic compound and use thereof. 2-1a1a2a3a1a2a1a2a313aabbaabbaabbaabb2aabb2a... |
|
|
Invention
|
Benzene fused heterocyclic derivative and pharmaceutical composition comprising the same. 22y1y2y... |
|
|
Invention
|
Use of nalmefene in non-alcoholic steatohepatitis.
The present invention relates to morphinans s... |
|
|
Invention
|
Sulfonamide or amide compounds, compositions and methods for the prophylaxis and/or treatment of ... |
|
2017
|
Invention
|
Morphinan derivatives and compositions comprising the same for treating autoimmune, inflammation ... |
|
|
Invention
|
Nalmefene, naltrexone or derivatives thereof for use in treating (non)-alcoholic steatohepatitis ... |
|
|
Invention
|
Use of nalmefene in non-alcoholic steatohepatitis. The present invention relates to new medical u... |
|
2016
|
Invention
|
Toll-like receptor 4 antagonists and use in autoimmune liver diseases. The present invention rela... |
|
2011
|
Invention
|
Opioid and opioid-like compounds and uses thereof. The present invention relates to opioid and op... |
|
2003
|
Invention
|
Chromones and chromone derivatives and uses thereof. Certain 2- and/or 3-substituted 5,6,7 substi... |
